Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02855138
Other study ID # 2016/358
Secondary ID
Status Completed
Phase Phase 4
First received August 1, 2016
Last updated August 4, 2016
Start date January 2015
Est. completion date June 2016

Study information

Verified date July 2016
Source Kayseri Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

The investigators consider that there are some rising concerns about the use of isotretinoin by women of reproductive age with depleted ovarian reserve, hence it is important to detect the effect of isotretinoin on ovarian reserve.

There has not been a well-designed study evaluating its effects on the human ovarian reserve, hormone levels and menstrual cycles in women with polycystic ovary syndrome (PCOS). For this reasons, this study was administered to determine whether there is an effect of isotretinoin on the gonads and hirsutism in women with acne and PCOS.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date June 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- consisted of 40 volunteers women with PCOS (aged 18- 40 years, BMI, 18-44kg/m2) who attended our obstetrics and gynecology clinic for the treatment menstrual irregularities and hirsutism

Exclusion Criteria:

- 1)presence of any dermatologic disorder besides acne 2) presence of any systemic disease 3) exposure to any systemic treatment in the last three months that could alter ovarian reserve 4) pregnancy or lactation 5) infection diseases 6) use of antidepressants, steroidal hormone drugs, mood stabilizers, caffeine, alcohol, or tobacco 7) histories of abdominal surgery for endometriosis or ovarian surgery

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Drug:
oral isotretinoin


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Kayseri Education and Research Hospital Kayseri Erciyes University Faculty of Medicine

Outcome

Type Measure Description Time frame Safety issue
Primary Adverse Events on the Gonads and Hirsutism That are Related to Treatment six months No
See also
  Status Clinical Trial Phase
Completed NCT04170088 - Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma Phase 2/Phase 3
Recruiting NCT05349851 - Bowel Cleansing With Renal Impairment
Active, not recruiting NCT01490060 - Fosaprepitant in Patients Receiving Ifosfamide-based Regimen N/A